Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure
Clinical trial NCT03254108 · COMPLETED
Trial details
- NCT number
- NCT03254108
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-06
- Primary completion
- 2018-04-14
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.